Health Systems Urged to Prepare for Rising AI Enforcement in Healthcare
As artificial intelligence becomes increasingly embedded in healthcare operations, regulatory scrutiny is expected to intensify—prompting organizations to strengthen governance, documentation, and oversight frameworks.
That is the assessment of Jeff Wurzburg, who warns that enforcement activity, while still in its early stages, will expand significantly in the coming years.
Enforcement Likely to Leverage Existing Frameworks
Rather than introducing a standalone AI regulator, enforcement is expected to evolve through established oversight mechanisms led by agencies such as the Centers for Medicare and Medicaid Services (CMS), the HHS Office of Inspector General, and the U.S. Department of Justice.
“As AI becomes embedded in functions like utilization management, coding, and clinical decision support, regulators will focus less on the technology itself and more on its impact on coverage decisions and claims accuracy,” Wurzburg said.
At the core of enforcement, he noted, will be accountability—particularly whether decisions influenced by AI can be justified under Medicare, Medicaid, and commercial payer rules.
Fraud, Compliance, and Payment Integrity Risks
The most immediate risks stem from existing fraud and abuse laws. Regulators are expected to scrutinize whether AI-driven processes introduce:
- Improper financial incentives
- Systemic upcoding or inappropriate denials
- Reduced transparency in clinical decision-making
Automation at scale could amplify these risks, increasing exposure under laws such as the False Claims Act.
At the same time, healthcare organizations must navigate a growing patchwork of state-level regulations, which may conflict with federal requirements and complicate compliance for multi-state providers.
Governance and Board-Level Accountability
Wurzburg emphasized that governance failures—rather than isolated clinical errors—are likely to be the primary source of liability.
Health system boards are expected to exercise informed oversight of AI tools, particularly where they influence patient safety, care quality, and reimbursement.
“Boards do not need to understand the technical mechanics of AI, but they must understand where it impacts clinical judgment and financial outcomes,” he said.
Organizations lacking structured governance—such as defined committees, risk assessments, and regular reporting—may face heightened scrutiny from regulators and legal stakeholders.
Data Privacy and Security Concerns
The integration of AI into clinical and operational workflows also raises significant data privacy risks under HIPAA.
Potential issues include:
- Unauthorized disclosure of protected health information (PHI)
- Opaque data usage by AI systems
- Misalignment between vendor practices and regulatory requirements
Healthcare providers remain accountable for compliance, even when AI tools are developed or managed by third-party vendors.
Addressing Bias and Discrimination Risks
Another key area of concern is algorithmic bias. AI systems trained on historical data may perpetuate disparities across race, age, disability, or other protected characteristics.
Such risks could trigger enforcement under civil rights laws, Medicare participation requirements, and state consumer protection regulations.
To mitigate exposure, organizations are advised to conduct rigorous vendor due diligence, maintain audit rights, and integrate AI oversight into broader compliance and quality programs.
Building a Strong Defense Strategy
In the event of regulatory investigations, defense strategies will focus less on the technology itself and more on demonstrating good-faith compliance with existing laws.
Key elements of a strong defense include:
- Evidence that AI tools functioned as decision support—not replacements for clinical judgment
- Alignment with established regulations, policies, and payer requirements
- Ongoing validation, monitoring, and corrective action processes
- Clear accountability structures and human oversight
Organizations must also ensure transparency in vendor relationships and avoid over-reliance on automated outputs.
Preparing for an Evolving Regulatory Landscape
As AI adoption accelerates, healthcare organizations are being urged to proactively strengthen governance and compliance frameworks.
“The key is not whether AI is used, but how it is governed,” Wurzburg noted.
With enforcement expected to grow alongside adoption, health systems that invest early in oversight, documentation, and accountability will be better positioned to navigate regulatory risks while leveraging AI to improve care delivery.
